Methyl 3-bromo-4-hydroxy-5-methoxybenzoate, 95.0%, 5g

2-Methylthiazole-4,5-dicarboxylic acid diethylester, 96.0%, 1g

GC capillary column ROTI®Cap-1701, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)

2-(2-Propoxyphenoxy)acetic acid, 95%, 1g

1,2-Bis(phenylthio)ethylene (cis- and trans- mixture)>98.0%(GC)5g

4-Bromo-N-methyl-3-methyl-2-nitroaniline, 95%, 100mg

2-METHYL-4-TRIFLUOROMETHOXYANILINE, 95.0%, 1g

4-CHLORO-5-ETHYNYLPYRIMIDIN-2-AMINE, 95.0%, 500mg

Tyr-Gly-Gly, 95.0%, 1g

1,1-difluorospiro[2.5]octan-6-ol, 95.0%, 250mg

(E)-2,2-Diphenyl-5-(4-((pyridin-3-ylmethylene)amino)piperazin-1-yl)pentanenitrile, 99%, 50mg

(4-Fluoro-3-methylphenyl)(4-fluorophenyl)methanone, 97%, 250mg